Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 223

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part II, Item 15
Chunk 223
---
470 $31,986 $260 $5 $201,721 Intersegment revenues2,336 3,901 39 (6,276)Net investment income91 376 222 18 707 Total revenues171,897 36,263 521 (6,253)202,428 Net investment results from certain equity method investments — (272)— — (272)Adjusted revenues$171,897 $35,991 $521 $(6,253)$202,156 Pharmacy and other service costs163,386 — Medical costs— 25,446 Selling, general and administrative expenses3,135 7,132 Other segment items (1)Interest (expense) and other(1)6 Less: Income attributable to noncontrolling interests342 — Pre-tax adjusted income (loss) from operations5,033 3,419 61 (1,192)7,321 Income (loss) before income taxes$4,101 $3,764 $(40)$(1,861)$5,964 Pre-tax adjustments to reconcile to adjusted income from operations(Income) attributable to noncontrolling interests(342)— — — (342)Net investment (gains) losses (2)(67)(285)2 2 (348)Amortization of acquired intangible assets1,262 18 — — 1,280 Special itemsStrategic optimization program83 14 99 370 566 Integration and transaction-related costs— — — 297 297 (Gain) on sale of businesses(4)(75)— — (79)(Benefits) associated with litigation matters— (17)— — (17)Pre-tax adjusted income (loss) from operations$5,033 $3,419 $61 $(1,192)$7,321 Other segment informationDepreciation and amortization$1,772 $252 $13 $16 $2,053 

(1)Other segment items represent the difference between segment adjusted revenues less significant segment expenses and pre-tax adjusted income (loss) from operations, and they do not represent significant segment items relative to the CODM's review and oversight.(2)Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its